Michael F. Huang insider trades
Open-market stock purchases and sales by Michael F. Huang, Sr. VP of Clinical Development at Soleno Therapeutics Inc, from SEC Form 4 filings since Jul 17, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | — |
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | $2.4M |
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | $679K |
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | $519K |
| Mar 27, 2026 | SLNO Soleno Therapeutics Inc | Sold | $128K |
| Mar 27, 2026 | SLNO Soleno Therapeutics Inc | Sold | $57K |
| Mar 27, 2026 | SLNO Soleno Therapeutics Inc | Sold | $15.5K |
| Jan 21, 2026 | SLNO Soleno Therapeutics Inc | Bought (not open market) | — |
| Jan 21, 2026 | SLNO Soleno Therapeutics Inc | Bought (not open market) | — |
| Dec 15, 2025 | SLNO Soleno Therapeutics Inc | Sold (not open market) | $40.6K |
Companies traded
- SLNO Soleno Therapeutics Inc: 12 sales, last May 18, 2026